Dr. Udit Narain Verma, MD

Dr. Verma practices at Charleston Area Medical Center General Hospital in Charleston, West Virginia, part of Vandalia Health.

Dr. Verma's NPI, 1033178165, was assigned on March 18, 2006. Dr. Verma graduated from King George's/CSM Medical College in 1983. Dr. Verma holds Texas license L6698.

Dr. Verma's primary practice is Charleston Area Medical Center General Hospital, at 501 Morris Street, Charleston, WV 25301 in Kanawha County. The practice phone is (304) 388-5432.

Dr. Verma's primary practice is Charleston Area Medical Center General Hospital in Charleston, West Virginia, part of Vandalia Health. Dr. Verma is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is Charleston Area Medical Center. Dmand AI also links Dr. Verma to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Verma practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Verma's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Verma is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Verma's licenses on file in 3 states: Texas, West Virginia and Iowa.

Dmand AI lists cardiac arrhythmia, fluid and electrolyte imbalances, gastrointestinal inflammation, joint pain and tobacco use among the conditions Dr. Verma treats.

CMS data shows 270 Medicare services from Dr. Verma across 6 procedure codes in 2024, for 102 Medicare patients. Medicare paid $16,822 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 102 Medicare patients who saw Dr. Verma in 2024. The largest group is 65 to 74, with 42 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Verma's median patient age at 64, with 49% women.

In 2024, Dr. Verma wrote 368 Medicare Part D claims for 63 patients. 85% of them were for generic drugs. CMS names the drug for 184 of them, across 9 drugs with 11 or more claims each, at $13,807 in total drug cost. In 2023, CMS named 265 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Verma for performance year 2024, reported through an alternative payment model (APM). Dr. Verma accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 35 papers to Dr. Verma, published from 2012 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Interleukin-2, Hematopoietic Stem Cells and Hematopoietic Stem Cell Transplantation. Dr. Verma has published most often in Bone Marrow Transplant. Dr. Verma's most frequent co-authors are Amitabha Mazumder, MD, Yull Edwin Arriaga, MD and Ronald Alan Sacher, MD.

Dmand AI links Dr. Verma to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include Carcinoma, Pancreatic Ductal, Rectal Neoplasms and Carcinoma, Ductal.

CMS Open Payments shows 25 general payments to Dr. Verma from 9 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 72% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $7,027.

Dmand AI lists 1 award for Dr. Verma, most recently CMS Stage 1 EHR in 2012.

Dr. Verma graduated from King George's/CSM Medical College in 1983.

Dr. Verma is in network with 23 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.